Placenta Diseases clinical trials
The registry lists 27 studies for Placenta Diseases across more than 10 countries. 6 are recruiting or about to start. 8 of them are mainly about Placenta Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-03. Counting its 5 narrower conditions too, such as Placenta Accreta: 317 studies, 77 open.
Get an email when these change. Save the Placenta Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Phase
- Phase 4
- 2
Who runs them
Manisa Celal Bayar University (3) · Celal Bayar University (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Maxima Medical Center (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Fundación Ginemed (1) · Dr. Laura Gaudet (1) · Manchester Academic Health Science Centre (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Effects of Tuberculosis Infection on Development and Function of the Placenta · Lund University
Who these studies take
Of the 3 Placenta Diseases studies recruiting now, 1 (33%) set no upper age limit and 2 (67%) stop at 75 or younger. 0 (0%) take children under 18. 3 (100%) are for women only and 0 (0%) for men only; 2 (67%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (100%) | 0 (0%) |
| 30 | 3 (100%) | 0 (0%) |
| 40 | 3 (100%) | 0 (0%) |
| 50 | 2 (67%) | 0 (0%) |
| 65 | 1 (33%) | 0 (0%) |
| 75 | 1 (33%) | 0 (0%) |
| 85 | 1 (33%) | 0 (0%) |
Across all 27 studies, recruiting or not: 56% stop at 75 or younger and 52% at 65; 11% take children; 96% are for women only and 0% for men only; 70% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Placenta Diseases studies take
Of 15 observational studies under Placenta Diseases, half reached primary completion within 22 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Observational | 22 mo13–56 · 15 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Effects of Tuberculosis Infection on Development and Function of the PlacentaRecruitingNCT063529701 country
- Characterization of Placental DiffusionRecruitingNCT06992245Not applicable1 country
- Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental DopplerNot yet recruitingNCT05284474Not applicable1 country
- Placenta Perfusion and Sufficiency StudyRecruitingNCT060423481 country
- Fetal, Obstetrics and Reproduction GenomicsNot yet recruitingNCT05720169
- Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"Not yet recruitingNCT058720091 country
- Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of MembraneCompletedNCT066399191 country
- Investigating CD 71 in Preeclamptic PregnanciesCompletedNCT066685451 country
- The Impact of Opioid and Cannabis Exposure on Fetal GrowthTerminatedNCT058991011 country
- Angiogenic Factors in the Placentas of Women With COVID-19CompletedNCT066445211 country
- Plasma Concentration of Biological Markers in Placenta Accreta SpectrumTerminatedNCT045255341 country
- Effects of Smoking on Placenta and LactationCompletedNCT064566451 country
- PregSource: Crowdsourcing to Understand PregnancyCompletedNCT025775361 country
- The START Clinic: a Feasibility StudyActive, not recruitingNCT044888611 country
- The Effect of Anemia in Adolescent and Advanced Age PregnanciesCompletedNCT056449641 country
- MARS: Magnetic Resonance Study: A Novel Assessment of Placental FunctionCompletedNCT037648781 country
- Near-infrared Spectroscopy: Differences in Placental Oxygenation in Relation to Ultrasound Maturation Grade in physiologIcal Term PregnanciesCompletedNCT057714151 country
- Prospective Study on Feto-maternal outcoMe In aNemIc womEnStatus unknownNCT057390971 country
- Placental Perfusion in the Entire Placenta and With Sonobiopsy by UltrasoundCompletedNCT05245279Not applicable1 country
- Ultrasound Diagnosis of Placental and Umbilical Cord Anomalies in Singleton Pregnancies Resulting From In-vitro FertilizationCompletedNCT051726741 country
- Imaging Innovations for Placental Assessment in Response to Environmental Pollution (PARENTs)CompletedNCT027864201 country
- COVID-19 Infection and Fetal-neonatal OutcomesStatus unknownNCT046995781 country
- Study on Retroplacental Hematomas in FinistèreCompletedNCT041686061 country
- Placental Volume Analysis During PregnanayStatus unknownNCT037319491 country
- Trial of Early Screening Test for Pre-eclampsia and Growth RestrictionCompletedNCT03674606Phase 41 country
- Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal PathwayCompletedNCT03636698
- Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in ZambiaCompletedNCT00270530Phase 41 country